4-nitroquinoline-1-oxide has been researched along with metformin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audic, N; Ermolenko, L; Franck, G; Garcia-Alvarez, MC; Martin, MT; Nhiri, N; Potier, P; Sasaki, NA; Wang, Q | 1 |
| Antony, B; Benny, M; Hicks, W; Jacob, T; Kulsum, S; Kumar, VV; Kuriakose, MA; Kuruvilla, BT; Lakshminarayan, P; Raghavan, N; Raju, N; Ravindra, DR; Seshadri, M; Sharma, A; Siddappa, G; Sudheendra, HV; Sunny, SP; Suresh, A | 1 |
2 other study(ies) available for 4-nitroquinoline-1-oxide and metformin
| Article | Year |
|---|---|
N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation.
Topics: beta-Alanine; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Glycation End Products, Advanced; Magnetic Resonance Spectroscopy; Peptides; Pyruvaldehyde | 2009 |
Curcumin and metformin-mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells.
Topics: 4-Nitroquinoline-1-oxide; AC133 Antigen; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Chemoprevention; Curcumin; Female; Hyaluronan Receptors; Hypoglycemic Agents; Metformin; Mice, Inbred C57BL; Mouth; Mouth Neoplasms; Neoplastic Stem Cells | 2017 |